As of 2025-05-15, the Intrinsic Value of Lasa Supergenerics Ltd (LASA.NS) is 0.57 INR. This LASA.NS valuation is based on the model Discounted Cash Flows (EBITDA Exit 10Y). With the current market price of 18.20 INR, the upside of Lasa Supergenerics Ltd is -96.90%.
The range of the Intrinsic Value is (1.40) - 4.66 INR
Based on its market price of 18.20 INR and our intrinsic valuation, Lasa Supergenerics Ltd (LASA.NS) is overvalued by 96.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (9.84) - (7.88) | (8.55) | -147.0% |
| DCF (Growth 10y) | (3.71) - (0.43) | (2.62) | -114.4% |
| DCF (EBITDA 5y) | (8.62) - (10.89) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (1.40) - 4.66 | 0.57 | -96.9% |
| Fair Value | -15.73 - -15.73 | -15.73 | -186.46% |
| P/E | (65.96) - (67.72) | (62.78) | -445.0% |
| EV/EBITDA | (0.68) - 2.46 | 0.50 | -97.3% |
| EPV | 29.32 - 42.00 | 35.66 | 95.9% |
| DDM - Stable | (13.59) - (33.71) | (23.65) | -230.0% |
| DDM - Multi | (2.95) - (5.78) | (3.91) | -121.5% |
| Market Cap (mil) | 911.82 |
| Beta | 0.57 |
| Outstanding shares (mil) | 50.10 |
| Enterprise Value (mil) | 1,102.90 |
| Market risk premium | 8.31% |
| Cost of Equity | 16.31% |
| Cost of Debt | 7.00% |
| WACC | 14.15% |